首页> 外文期刊>Journal of Korean Neurosurgical Society >The Role of Radiosurgery in Patients with Brain Metastasis from Small Cell Lung Carcinoma
【24h】

The Role of Radiosurgery in Patients with Brain Metastasis from Small Cell Lung Carcinoma

机译:放射外科在小细胞肺癌脑转移患者中的作用

获取原文
           

摘要

Objective The purpose of this retrospective study was to evaluate the outcome of gamma knife radiosurgery (GKRS) and/or whole brain radiation therapy (WBRT) for the treatment of small cell lung carcinoma (SCLC) metastasis to the brain. Methods From 2000 to 2010, 50 patients underwent GKRS for metastatic brain lesions originating from SCLC. Among these patients, 11 received prophylactic cranial irradiation (PCI) before the development of metastatic lesions (PCI group), and GKRS was performed as an initial treatment for newly diagnosed lesions in 12 patients who had not received PCI (primary GKRS group). In addition, GKRS was performed as a salvage treatment for progressive lesions after WBRT in 27 patients (salvage GKRS group). The medical records and imaging data of all patients were retrospectively analyzed. Results The overall survival of the 50 patients was 20.8 months (range 1-53) after the diagnosis of primary tumor and 12.0 months (range 1-47) after the development of cerebral metastasis. Median survival after GKRS was 4.8 months (range 1-15) in the PCI group, 4.6 months (range 0-18) in the primary GKRS group, and 7.6 months (range 0-33) in the salvage GKRS group. Further treatment for progressive lesions after GKRS was necessary in 15 patients, after a mean interval of 3.8 months. Causes of death were systemic organ failure in 15 patients, deterioration of neurological state in 13 patients, and unknown or combined causes in 16 patients. The local control rate of the lesions treated with GKRS was 76.4% (decreased in 13 patients and stable in 16 patients at the final imaging follow-up (mean 5.60 months). Conclusion GKRS is an effective local treatment for brain metastasis from SCLC both as an initial treatment for newly diagnosed lesions after PCI and as a salvage treatment for recurrent or progressive lesions. However, the survival benefit is not significant because most patients die of systemic multi-organ failure with a short life expectancy.
机译:目的这项回顾性研究的目的是评估伽玛刀放射外科(GKRS)和/或全脑放射治疗(WBRT)治疗小细胞肺癌(SCLC)转移至脑部的结果。方法2000年至2010年,对50例因SCLC引起的转移性脑病变进行了GKRS的患者。在这些患者中,有11例在转移性病变发展之前接受了预防性颅脑照射(PCI)(PCI组),而GKRS作为12例未接受PCI的新诊断病变的初始治疗(主要GKRS组)。此外,对27例患者进行了WBRT后进行性病变的抢救治疗(抢救性GKRS组)。回顾性分析所有患者的病历和影像数据。结果50例患者的总生存时间为原发肿瘤诊断后20.8个月(1-53范围),脑转移发生后12.0个月(1-47范围)。在PCI组中,GKRS术后中位生存期为4.8个月(范围1-15),在原发性GKRS组中为4.6个月(范围0-18),而在挽救性GKRS组中为7.6个月(范围0-33)。平均间隔3.8个月后,有15位患者需要进一步治疗GKRS后的进行性病变。死亡原因为系统性器官衰竭15例,神经系统状态恶化13例,未知或综合原因16例。在最后一次影像学随访(平均5.60个月)后,GKRS治疗的病灶的局部控制率为76.4%(降低13例,稳定16例),结论GKRS是SCLC的一种有效的局部治疗SCLC脑转移的方法。 PCI后作为新诊断病变的初始治疗以及复发性或进行性病变的挽救性治疗,但是,由于大多数患者死于系统性多器官功能衰竭且寿命短,因此其生存获益并不显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号